825 related articles for article (PubMed ID: 11082299)
1. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of spermine depletion by N-cyclohexyl-1,3-diaminopropane in human breast cancer cells.
Huber M; Poulin R
Cancer Res; 1995 Feb; 55(4):934-43. PubMed ID: 7850811
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
[TBL] [Abstract][Full Text] [Related]
5. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
6. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
Aziz SM; Gillespie MN; Crooks PA; Tofiq SF; Tsuboi CP; Olson JW; Gosland MP
J Pharmacol Exp Ther; 1996 Jul; 278(1):185-92. PubMed ID: 8764350
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of polyamine synthesis and growth by difluoromethylornithine plus methylthioadenosine in methylthioadenosine phosphorylase-deficient murine lymphoma cells.
Yamanaka H; Kubota M; Carson DA
Cancer Res; 1987 Apr; 47(7):1771-4. PubMed ID: 3102048
[TBL] [Abstract][Full Text] [Related]
8. Amino acid/spermine conjugates: polyamine amides as potent spermidine uptake inhibitors.
Burns MR; Carlson CL; Vanderwerf SM; Ziemer JR; Weeks RS; Cai F; Webb HK; Graminski GF
J Med Chem; 2001 Oct; 44(22):3632-44. PubMed ID: 11606128
[TBL] [Abstract][Full Text] [Related]
9. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines.
Sandgren S; Belting M
Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
Heston WD; Kadmon D; Covey DF; Fair WR
Cancer Res; 1984 Mar; 44(3):1034-40. PubMed ID: 6420052
[TBL] [Abstract][Full Text] [Related]
11. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a polyamine transport deficient cell line from the human non-small cell lung carcinoma line NCI H157.
Shao D; Xiao L; Ha HC; Casero RA
J Cell Physiol; 1996 Jan; 166(1):43-8. PubMed ID: 8557774
[TBL] [Abstract][Full Text] [Related]
13. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
14. Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines.
Porter CW; Ganis B; Libby PR; Bergeron RJ
Cancer Res; 1991 Jul; 51(14):3715-20. PubMed ID: 2065327
[TBL] [Abstract][Full Text] [Related]
15. Benefits of complete polyamine deprivation in hormone responsive and hormone resistant MCF-7 human breast adenocarcinoma in vivo.
Leveque J; Foucher F; Havouis R; Desury D; Grall JY; Moulinoux JP
Anticancer Res; 2000; 20(1A):97-101. PubMed ID: 10769640
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
[TBL] [Abstract][Full Text] [Related]
17. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2007 Sep; 105(1):29-36. PubMed ID: 17143592
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
Gawel-Thompson KJ; Greene RM
J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the Na(+)-dependent and the Na(+)-independent polyamine transporters in renal epithelial cells (LLC-PK1).
Parys JB; De Smedt H; Van Den Bosch L; Geuns J; Borghgraef R
J Cell Physiol; 1990 Sep; 144(3):365-75. PubMed ID: 2118145
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
Porter CW; Bernacki RJ; Miller J; Bergeron RJ
Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]